Literature DB >> 17141805

Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.

Alok Mulky1, B Christie Vu, Joan A Conway, Stephen H Hughes, John C Kappes.   

Abstract

The HIV-1 p51/p66 reverse transcriptase (RT) heterodimer interface comprises, in part, intermolecular interaction of the loop region between beta-strands 7 and 8 (beta7-beta8 loop) in the p51 fingers subdomain with the p66 palm subdomain. In this study, for the first time in the context of infectious HIV-1 particles, we analyzed the contribution of amino acid residues (S134, I135, N136, N137, T139 and P140) in the beta7-beta8 loop for RT heterodimerization, enzymatic activity, and virus infectivity. Mutating asparagine 136 to alanine (N136A) reduced viral infectivity and enzyme activity dramatically. The N136A mutation appeared to destabilize the RT heterodimer and render both the p66 and p51 subunits susceptible to aberrant cleavage by the viral protease. Subunit-specific mutagenesis demonstrated that the presence of the N136A mutation in the p51 subunit alone was sufficient to cause degradation of RT within the virus particle. Alanine mutation at other residues of the beta7-beta8 loop did not affect either RT stability or virus infectivity significantly. None of the beta7-beta8 loop alanine mutations affected the sensitivity of virus to inhibition by NNRTIs. In the context of infectious virions, our results indicate a critical role of the p51 N136 residue within the beta7-beta8 loop for RT heterodimer stability and function. These findings suggest the interface comprising N136 in p51 and interacting residues in p66 as a possible target for rational drug design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141805     DOI: 10.1016/j.jmb.2006.10.089

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.

Authors:  Isabel Olivares; Alok Mulky; Peter I Boross; József Tözsér; John C Kappes; Cecilio López-Galíndez; Luis Menéndez-Arias
Journal:  J Mol Biol       Date:  2007-07-03       Impact factor: 5.469

2.  Peptides Mimicking the β7/β8 Loop of HIV-1 Reverse Transcriptase p51 as "Hotspot-Targeted" Dimerization Inhibitors.

Authors:  Pedro A Sánchez-Murcia; Sonia de Castro; Carlos García-Aparicio; M Angeles Jiménez; Angela Corona; Enzo Tramontano; Nicolas Sluis-Cremer; Luis Menéndez-Arias; Sonsoles Velázquez; Federico Gago; María-José Camarasa
Journal:  ACS Med Chem Lett       Date:  2020-01-24       Impact factor: 4.345

3.  Homodimerization of the p51 subunit of HIV-1 reverse transcriptase.

Authors:  Xunhai Zheng; Geoffrey A Mueller; Matthew J Cuneo; Eugene F Derose; Robert E London
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

4.  Basis for early and preferential selection of the E138K mutation in HIV-1 reverse transcriptase.

Authors:  Matthew McCallum; Maureen Oliveira; Ruxandra-Ilinca Ibanescu; Victor G Kramer; Daniela Moisi; Eugene L Asahchop; Bluma G Brenner; P Richard Harrigan; Hongtao Xu; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

5.  The "Connection" Between HIV Drug Resistance and RNase H.

Authors:  Krista A Delviks-Frankenberry; Galina N Nikolenko; Vinay K Pathak
Journal:  Viruses       Date:  2010-07-01       Impact factor: 5.048

6.  Asymmetric conformational maturation of HIV-1 reverse transcriptase.

Authors:  Xunhai Zheng; Lalith Perera; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Elife       Date:  2015-06-03       Impact factor: 8.140

Review 7.  Structural Maturation of HIV-1 Reverse Transcriptase-A Metamorphic Solution to Genomic Instability.

Authors:  Robert E London
Journal:  Viruses       Date:  2016-09-27       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.